COLL
Collegium Pharmaceutical, IncCompany with tickers: COLL
CIK
1267565
CUSIP
19459J104
Shares Outstanding
32,433,779
13F Activity (30d)
224 filings
221 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $193,520,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | $117,246,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $86,350,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | — | ||||
| Operating Income | $30,896,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $14,496,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.45 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.40 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |